EXOZYMES INC. (EXOZ) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $9.00; Additional Paid in Capital, Common StockUSD $729.19K; Additional Paid in CapitalUSD $30.01M; Retained Earnings (Accumulated Deficit)USD $-26.35M.
- 2026-03-31: Common Stock, Value, IssuedUSD $8.00; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $25.00M; Retained Earnings (Accumulated Deficit)USD $-23.47M.
- 2025-12-31: Common Stock, Value, IssuedUSD $8.00; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $24.50M; Retained Earnings (Accumulated Deficit)USD $-21.10M.
- 2025-09-30: Common Stock, Value, IssuedUSD $8.00; Additional Paid in Capital, Common StockUSD (m); Additional Paid in CapitalUSD $23.82M; Retained Earnings (Accumulated Deficit)USD $-18.45M.
EXOZYMES INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $9.00 | $729.19K | $30.01M | $-26.35M | $3.65M | 3 month · $961.07K | (m) | (m) |
| 2026-03-31 | $8.00 | (m) | $25.00M | $-23.47M | $1.53M | 3 month · $501.10K | (m) | (m) |
| 2025-12-31 | $8.00 | (m) | $24.50M | $-21.10M | $3.40M | 12 month · $1.65M | (m) | 12 month · $147.10K |
| 2025-09-30 | $8.00 | (m) | $23.82M | $-18.45M | $5.37M | (m) | (m) | (m) |
| 2025-06-30 | $8.00 | (m) | $23.40M | $-16.16M | $7.24M | (m) | (m) | 3 month · $147.10K |
| 2025-03-31 | $8.00 | (m) | $22.68M | $-13.80M | $8.88M | 3 month · $317.28K | (m) | (m) |
| 2024-12-31 | $8.00 | (m) | $22.37M | $-11.95M | $10.42M | 12 month · $1.13M | 12 month · $11.82K | (m) |
| 2024-09-30 | $6.00 | (m) | $6.51M | $-10.11M | $-3.60M | 3 month · $317.28K | (m) | (m) |
| 2024-06-30 | (m) | (m) | (m) | (m) | $-2.26M | 3 month · $348.27K | (m) | (m) |
| 2024-03-31 | (m) | (m) | (m) | (m) | $-1.25M | 3 month · $142.81K | (m) | (m) |
| 2023-12-31 | $6.00 | (m) | $5.70M | $-6.08M | $-384.32K | 12 month · $281.54K | (m) | (m) |
| 2023-09-30 | (m) | (m) | (m) | (m) | $607.14K | 3 month · $61.36K | (m) | (m) |
| 2023-06-30 | (m) | (m) | (m) | (m) | $1.07M | 3 month · $58.95K | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | $1.19M | 3 month · $54.12K | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | $1.37M | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |